Rs 800 for each Nasal Vaccine against COVID

New Delhi:  A single dose of Bharat Biotech’s intranasal vaccine iNCOVACC is expected to cost around Rs 800. According to sources, there will be 5 per cent GST on this vaccine in private hospitals. Meanwhile, the vaccine will cost Rs 325 to the government. Last week this nasal vaccine was approved for use in India’s Covid-19 immunisation programme.

This nasal vaccine will be first available in private hospitals. The nasal vaccine, BBV154, received approval from the Drugs Controller General of India (DCGI) in November for restricted use in an emergency situation for those above 18 years as a heterologous booster dose.

The vaccine was designated as the “World’s First Intra-Nasal COVID Vaccine Developed by India” by the Ministry of Science. The vaccine was created in collaboration with Washington University in St. Louis, which also developed it and tested its efficacy in preclinical tests. Bharat Biotech carried out product development activities related to preclinical safety assessment, large-scale manufacturing scale-up, formulation, and delivery device development, including human clinical trials.

Comments are closed.